Publication | Open Access
The ethical imperative for shared decision-making
134
Citations
1
References
2013
Year
Ethical DilemmaClinical Decision-makingEthical ImperativeLawDecision ScienceHealth Care FinanceHealth LawMedical Decision MakingRation CareApplied EthicEthical AnalysisPublic HealthGood Clinical PracticeHealth PolicyHealthcare Decision-makingDecision AidOutcomes ResearchClinical Decision SupportMedical Decision AnalysisMedical EthicsDecision-makingHealth Care ReimbursementPatient SafetyPatient-centered OutcomeMarginal BenefitsMedicineSocial Responsibility
Shared decision‑making, promoted by the Affordable Care Act as a core of person‑centered care, faces distortions that prioritize cost‑saving over patient preference, misrepresenting its principle of respecting informed choices and highlighting that many therapies offer only marginal benefits. The study aims to clarify that shared decision‑making should expose harm‑benefit trade‑offs to patients rather than serve as a tool for rationing care. The authors argue that, alongside other strategies, shared decision‑making can realign clinicians with patients’ informed preferences, placing patients—not cost considerations—at the center of care.
The promotion of shared decision-making is a central policy initiative in the Patient Protection and Affordable Care Act and a key component of person-centered medicine. Yet, as interest increases, disturbing distortions of shared decision-making have occurred. Fueled by a desire to reduce healthcare costs, reduce litigation and improve cost-effectiveness, the underlying rationale for shared decision-making risks being overshadowed and some portray shared decision-making as a method to bend the cost curve. Opponents of shared decision-making claim it is a ploy to ration care to patients [1]. Both these positions misrepresent the underpinning principles. The imperative for shared decision-making rests on the principles of good clinical practice, respecting patients’ right to know: that their informed preferences should be the basis for professional actions. Evidence-based medicine has contributed to our understanding that many therapies have marginal benefits. Shared decision-making aims to make the trade-offs between harms and benefits evident to patients rather than ration care. Overutilization arguably arises out of undue corporate influence on the promotion of marginally efficacious therapies with distorted claims of benefit. Other methods should be used to tackle these wider challenges, while the practice of shared decision-making would help medical professionals re-align themselves with patients’ informed preferences and, in so doing, place patients, not making or saving money, at the center of care.
| Year | Citations | |
|---|---|---|
Page 1
Page 1